1-4 of 4
Steven D Rhodes
Close
Sort by
Journal Articles

Efficacy of the Allosteric MEK Inhibitor Trametinib in Relapsed and Refractory Juvenile Myelomonocytic Leukemia: A Report from the Children's Oncology Group

Elliot Stieglitz, Alex Lee, Steven P. Angus, Christopher Davis, Donald Barkauskas, David Hall, Scott C. Kogan, Julia Meyer, Steven D. Rhodes, Xiaoling Xuei, Kevin Shannon, Mignon L. Loh, Elizabeth Fox, Brenda J. Weigel
Journal: Blood
Blood (2023) 142 (Supplement 1): 74.
https://doi.org/10.1182/blood-2023-173153
Published: 2023
Journal Articles

Haploinsufficiency of Nf1 in Myeloid Lineages Contributes to Neurofibromatosis Type 1 Associated Skeletal Deficits

Steven D. Rhodes, Yongzheng He, M.D., Shi Chen, Hao Yang, Keshav M. Menon, Karl Staser, Ph.D., Xianlin Yang, Khalid S. Mohammad, M.D. Ph.D., Theresa Guise, M.D., Mingjiang Xu, M.D., Ph.D., Feng-chun Yang, M.D., Ph.D.
Journal: Blood
Blood (2012) 120 (21): 830.
https://doi.org/10.1182/blood.V120.21.830.830
Published: 2012
Journal Articles

Normal Hematopoiesis and Neurofibromin -Deficient Myeloproliferative Disease Require Erk

Karl Staser, PhD, Yi Zeng, MD, PhD, Su-jung Park, PhD, Steven D. Rhodes, Yongzheng He, M.D., Matthew A. Shew, Jeff Gehlhausen, Donna Cerabona, Shi Chen, Zejin Sun, MD, PhD, Grzegorz Nalepa, MD, PhD, Feng-chun Yang, M.D., Ph.D., D. Wade Clapp, MD
Journal: Blood
Blood (2012) 120 (21): 704.
https://doi.org/10.1182/blood.V120.21.704.704
Published: 2012
Journal Articles

Erk1 Plays Critical Role in Macrophage Development

Yongzheng He, MD, Karl Staser, PhD, Steven D Rhodes, Xiaohua Wu, Ping Zhang, Shi Chen, Feng-chun Yang, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 517.
https://doi.org/10.1182/blood.V118.21.517.517
Published: 2011